Literature DB >> 16314470

Macrophage migration inhibitory factor: a central regulator of wound healing.

Matthew J Hardman1, Alexander Waite, Leo Zeef, Matthew Burow, Toshinori Nakayama, Gillian S Ashcroft.   

Abstract

Age-associated differences in estrogen levels critically modify the cutaneous wound healing response. Using a microarray-based approach, we profiled changes in gene expression within the wounds of mice that were wild type or null for the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) in the presence or absence of estrogen. This experimental design identified more than 600 differentially expressed genes and established MIF as a key player in the wound healing process, regulating many novel repair/inflammation-associated gene targets. Moreover, MIF affected virtually all of the effects of reduced estrogen on wound repair. In humans, serum and wound levels of MIF increased with age and were strongly down-regulated by estrogen in vivo. Estrogen-regulated MIF transcription in vitro via a nuclear factor kappaB-dependent mechanism. These findings have wide-ranging implications for the many pathophysiological states in which MIF plays an important regulatory role and suggest a potential therapeutic role for MIF in modulating clinical conditions associated with age-related decline in estrogen levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314470      PMCID: PMC1613193          DOI: 10.1016/S0002-9440(10)61241-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 2.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice.

Authors:  X Huang; M Griffiths; J Wu; R V Farese; D Sheppard
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis.

Authors:  Sudesh Agrawal; Munna L Agarwal; Moitreyee Chatterjee-Kishore; George R Stark; Guy M Chisolm
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.

Authors:  Fiona G Brown; David J Nikolic-Paterson; Prudence A Hill; Nicole M Isbel; John Dowling; Christine M Metz; Robert C Atkins
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

6.  Mice with combined disruption of Gpx1 and Gpx2 genes have colitis.

Authors:  R S Esworthy; R Aranda; M G Martín; J H Doroshow; S W Binder; F F Chu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

7.  Macrophage migration inhibitory factor increases MMP-2 activity in DU-145 prostate cells.

Authors:  K Meyer-Siegler
Journal:  Cytokine       Date:  2000-07       Impact factor: 3.861

8.  Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo.

Authors:  M J Evans; A Eckert; K Lai; S J Adelman; D C Harnish
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

9.  Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers.

Authors:  David J Margolis; Jill Knauss; Warren Bilker
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

10.  A proinflammatory cytokine inhibits p53 tumor suppressor activity.

Authors:  J D Hudson; M A Shoaibi; R Maestro; A Carnero; G J Hannon; D H Beach
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more
  29 in total

1.  Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.

Authors:  Mark A Barnes; Megan R McMullen; Sanjoy Roychowdhury; Nabil Z Madhun; Kathryn Niese; Mitchell A Olman; Abram B Stavitsky; Richard Bucala; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2014-11-14       Impact factor: 4.962

2.  Caveolin-1 as a novel indicator of wound-healing capacity in aged human corneal epithelium.

Authors:  Ji Heon Rhim; Jae Hoon Kim; Eui-Ju Yeo; Jae Chan Kim; Sang Chul Park
Journal:  Mol Med       Date:  2010-07-14       Impact factor: 6.354

3.  Identification and expression of macrophage migration inhibitory factor in Sarcoptes scabiei.

Authors:  N M Cote; D C Jaworski; N B Wasala; M S Morgan; L G Arlian
Journal:  Exp Parasitol       Date:  2013-07-04       Impact factor: 2.011

4.  Estrogen receptor-alpha promotes alternative macrophage activation during cutaneous repair.

Authors:  Laura Campbell; Elaine Emmerson; Helen Williams; Charis R Saville; Andrée Krust; Pierre Chambon; Kimberly A Mace; Matthew J Hardman
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

5.  17beta-estradiol inhibits wound healing in male mice via estrogen receptor-alpha.

Authors:  Stephen C Gilliver; Elaine Emmerson; Laura Campbell; Pierre Chambon; Matthew J Hardman; Gillian S Ashcroft
Journal:  Am J Pathol       Date:  2010-05-06       Impact factor: 4.307

6.  Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction.

Authors:  James M Harper; J Erby Wilkinson; Richard A Miller
Journal:  FASEB J       Date:  2010-03-10       Impact factor: 5.191

7.  Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.

Authors:  Douglas Arenberg; Tracy R Luckhardt; Shannon Carskadon; Liujian Zhao; Mohammad A Amin; Alisa E Koch
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

8.  Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

Authors:  C Herder; N Klopp; J Baumert; M Müller; N Khuseyinova; C Meisinger; S Martin; T Illig; W Koenig; B Thorand
Journal:  Diabetologia       Date:  2007-08-22       Impact factor: 10.122

9.  Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

Authors:  Mathias Krockenberger; Yvonne Dombrowski; Claudia Weidler; Monika Ossadnik; Arnd Hönig; Sebastian Häusler; Heike Voigt; Jürgen C Becker; Lin Leng; Alexander Steinle; Michael Weller; Richard Bucala; Johannes Dietl; Jörg Wischhusen
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Immune mediators in patients with acute diabetic foot syndrome.

Authors:  Christian Weigelt; Bettina Rose; Ulrike Poschen; Dan Ziegler; Gerd Friese; Kerstin Kempf; Wolfgang Koenig; Stephan Martin; Christian Herder
Journal:  Diabetes Care       Date:  2009-06-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.